ISSN: ISSN 2472-016X

整形外科腫瘍学ジャーナル

オープンアクセス

当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Oncologic Orthopedics: From Diagnosis to Rehabilitation

Solomon Dada

Oncologic orthopedics, the specialized field dedicated to the diagnosis and treatment of musculoskeletal tumors and related conditions, has made significant strides in recent years. From early detection through advanced imaging techniques to comprehensive rehabilitation programs, this article explores the entire continuum of care for patients facing bone and soft tissue malignancies. The journey of a patient through oncologic orthopedics encompasses various stages, each of which plays a vital role in optimizing outcomes and improving the quality of life for those affected by these challenging conditions. Oncologic orthopedics acknowledges that successful treatment extends beyond tumor eradication. Comprehensive rehabilitation programs are integral to help patients regain function and quality of life following surgery or other therapies. Physical therapy, occupational therapy, and pain management interventions play pivotal roles in restoring mobility, strength, and functionality. Moreover, psychological support and counseling are equally important to address the emotional and mental aspects of the patient’s journey.

Oncologic orthopedics, a specialized branch of medicine that combines the fields of oncology and orthopedic surgery, plays a crucial role in the diagnosis, treatment, and rehabilitation of patients with musculoskeletal tumors. From the initial diagnosis to the comprehensive rehabilitation process, this article explores the continuum of care provided by oncologic orthopedic specialists. By highlighting the multidisciplinary approach and advancements in each stage of patient management, we can gain insights into how modern medicine is continuously striving to improve outcomes and enhance the quality of life for those affected by bone and soft tissue malignancies.